Excessive activation of *N*-methly *D*-aspartate (NMDA)-type glutamate receptors leads to excitotoxic cell death in acute neurological disorders, such as stroke and trauma, and also in chronic disorders, such as Alzheimer\'s disease.^[@bib1],\ [@bib2],\ [@bib3],\ [@bib4]^ Cell death in excitotoxicity requires the calcium-dependent production of both nitric oxide and superoxide.^[@bib5],\ [@bib6],\ [@bib7],\ [@bib8],\ [@bib9]^ Nitric oxide is produced by neuronal nitric oxide synthase, in response to calcium entry through NMDA receptors.^[@bib8]^ Superoxide production was long considered a result of mitochondrial calcium uptake;^[@bib10],\ [@bib11]^ however, recent studies suggest instead that NADPH oxidase is the major source of NMDA-induced superoxide production.^[@bib5],\ [@bib12],\ [@bib13],\ [@bib14],\ [@bib15]^ Neuronal NADPH oxidase has also been identified as a primary source of brain oxidative stress in stroke, aging, and other disorders,^[@bib16],\ [@bib17],\ [@bib18]^ but little is known about the regulation of neuronal NADPH oxidase.

NOX2 is the isoform of NADPH oxidase most abundantly expressed by brain neurons.^[@bib19]^ NOX2 is also the most abundant isoform expressed by phagocytes, where its regulation and function have been extensively studied. NOX2 is composed of two membrane bound subunits, p22^phox^ and gp91^phox^ (the catalytic unit), and three cytosolic subunits, p47^phox^, p67^phox^, and p40^phox^. Phosphorylation of p47^phox^ induces its translocation to cell membranes, where it interacts with the other subunits, membrane phospholipids, and Rac GTPase to form an active enzyme complex.^[@bib19],\ [@bib20]^ p47^phox^ is phosphorylated by protein kinase C (PKC), with different PKC subtypes utilized in different cell types. In neurons, inhibition of the calcium-insensitive PKC subtype, PKC zeta (PKC*ζ)*, prevents NMDA-induced superoxide production,^[@bib5]^ but how NMDA receptor activation triggers PKC*ζ* activation and subsequent NOX2 activation remains unresolved.

Phosphoinositide 3-kinase (PI3K) is also induced by NMDA receptor activation.^[@bib21],\ [@bib22],\ [@bib23]^ PI3K phosphorylates the three position of hydroxyl groups on the inositol ring of specific phosphatidylinositol membrane phospholipids.^[@bib24]^ PI3K activation engages prosurvival signaling pathways in many cell types, and in the central nervous system PI3K is also involved in neuronal plasticity.^[@bib21],\ [@bib25]^ However, PI3K activation has also been associated with neuronal death in some settings,^[@bib26],\ [@bib27]^ by mechanisms yet to be established

Here, we show that PI3K couples NMDA receptors to PKC*ζ* activation, NOX2 activation, and excitotoxic cell death. Inhibition of the PI3K signaling pathway blocks NOX2 activation, superoxide formation, and cell death, without blocking NMDA-induced calcium influx, cell swelling, or mitochondrial depolarization. These findings demonstrate a novel role for PI3K in regulating neuronal superoxide production, and suggest a shared signaling pathway underlying plasticity and excitotoxic death in the nervous system.

Results
=======

NMDA-induced superoxide production requires activation of NOX2
--------------------------------------------------------------

Mouse cortical neuron cultures treated with NMDA exhibited dose-dependent superoxide formation and cell death ([Figures 1a and b](#fig1){ref-type="fig"}). These neurons exhibited characteristic features of excitotoxicity: intracellular calcium elevation, cell swelling, superoxide formation, mitochondrial depolarization, and subsequent cell death ([Figures 1](#fig1){ref-type="fig"} and 3). Superoxide production was assessed using two independent methods; formation of 4-hydroxynonenal (4HNE) from native lipids,^[@bib28]^ and formation of oxidized ethidium species (Eth) from dihydroethidium^[@bib29],\ [@bib30]^ ([Figures 1c--f](#fig1){ref-type="fig"}). Formation of both 4HNE and Eth were blocked in cultures treated with a peptide inhibitor of NOX2 assembly, gp91ds-Tat.^[@bib31]^ ([Figures 1c--f](#fig1){ref-type="fig"}), thus confirming that these outcome measures are detecting superoxide in these studies. NMDA-induced superoxide production was similarly absent in cultures prepared from p47^phox−/−^ mice, which are unable to form a functional NOX2 complex.^[@bib19]^ However, when p47^phox^ expression was reconstituted in these cultures by transfection, both NMDA-induced superoxide production and cell death were detected in the neighborhood of the transfected cells ([Figure 2](#fig2){ref-type="fig"}). The intracellular superoxide detection and cell death in these neighboring cells were negated by the addition of superoxide dismutase in the medium ([Figure 2d](#fig2){ref-type="fig"}), further confirming that the superoxide produced enters the extracellular space.^[@bib15]^

NMDA-induced NOX2 activation requires calcium entry through NR2B-containing NMDA receptors
------------------------------------------------------------------------------------------

NMDA receptors are heterodimers that typically contain an NR1 subunit paired with either an NR2A or NR2B subunit, of which the NR2B subunit has been functionally linked to cell death.^[@bib32],\ [@bib33]^ To determine whether NR2B subunits are involved in superoxide production, cultures were treated with NMDA in the presence of the NR2B-selective antagonist, Ro 25-6981.^[@bib34]^ Ro 25-6981 blocked the superoxide production ([Figure 1](#fig1){ref-type="fig"}) and cell death ([Figures 3a and b](#fig3){ref-type="fig"}) otherwise produced by NMDA.

Calcium influx is required for both NMDA-induced neuronal death and NOX2 activation.^[@bib5],\ [@bib35]^ To determine whether the calcium influx route is an important factor, we compared the effects of NMDA and the calcium ionophore ionomycin, using ionomycin at concentrations that generated a rate and magnitude of calcium elevation comparable to that induced by 100 *μ*M NMDA. Under these conditions, both NMDA and ionomycin-induced mitochondrial membrane depolarization, but only NMDA-induced superoxide production and cell death ([Figure 3](#fig3){ref-type="fig"}). In both conditions, the extent of mitochondrial membrane potential was incomplete relative to that caused by FCCP. Intracellular calcium measurements were also performed using the low affinity calcium indicator Fura-FF to reduce the possibility that non-linear dye responses, averaging of heterogeneous intracellular compartments, zinc binding, or calcium saturation of the high-affinity Fura-2 dye were masking differences in calcium elevations produced by NMDA and ionomycin.^[@bib36],\ [@bib37]^ The studies using high- and low-affinity calcium dyes gave similar results ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}).

Of note, ionomycin-induced superoxide production was observed when ionomycin was used at a concentration (10 *μ*M) that produced far higher calcium elevations than produced by NMDA ([Supplementary Figure 2](#sup1){ref-type="supplementary-material"}). However, the superoxide production induced by 10 *μ*M ionomycin was not diminished by NOX2 inhibition, consistent with the report that very high calcium elevations can induce neuronal superoxide production by a source other than NOX2.^[@bib38]^

NMDA-induced NOX2 activation requires PI3K activation
-----------------------------------------------------

NOX2 activation requires phosphorylation of its p47^phox^ subunit, a process performed by different PKC isoforms in different cell types.^[@bib19]^ Our finding that ionomycin-induced calcium elevations do not activate neuronal NOX2 suggests the involvement of an 'atypical\' PKC isoform, activated by signals other than calcium elevation. PKC*ζ* is an atypical PKC previously linked to neuronal NOX2 activation,^[@bib5]^ and PKC*ζ* is activated by PI3K.^[@bib20]^ Given that PI3K activation can be triggered by calcium entry specifically through NMDA receptors,^[@bib22],\ [@bib39]^ we evaluated the role of PI3K in NMDA-induced NOX2 activation. Neurons exposed to NMDA with the PI3K inhibitor, wortmannin, showed greatly attenuated superoxide formation and cell death ([Figures 4a--d](#fig4){ref-type="fig"}). Wortmannin did not, however, block other aspects of NMDA receptor activation; intracellular calcium elevation, mitochondrial depolarization, or cell swelling ([Figures 4e--h](#fig4){ref-type="fig"}).

To confirm that the wortmannin effect on NOX2 activation is caused specifically by PI3K inhibition, we supplied wortmannin-treated cultures with the phosphatidylinositol (3,4,5)-triphosphate (PI(3,4,5)P3) product of PI3K using a BODIPY-tagged lipid carrier.^[@bib40]^ The exogenous PI(3,4,5)P3 did not itself induce superoxide production, but did restore NMDA-induced superoxide production in the wortmannin-treated cultures ([Figures 5a and b](#fig5){ref-type="fig"}). By contrast, treatment with the PI3K substrate, phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), did not reconstitute superoxide production.

PI3K activates neuronal NOX2 by activating PKC*ζ*
-------------------------------------------------

If PI3K functions to activate PKC*ζ* in this signaling pathway, then the effects of PI3K inhibition should be circumvented in neurons expressing a constitutively active PKC*ζ*. We tested this idea by transfecting neurons with protein kinase M (PKM), a truncated, constitutively active form of PKC*ζ*.^[@bib41],\ [@bib42]^ PKM expression did not induce superoxide production in the absence of NMDA, but it did restore NMDA-induced superoxide production in the wortmannin-treated cultures ([Figures 5c and d](#fig5){ref-type="fig"}). This observation confirms both that PKC*ζ* activity is essential in this pathway, and that PKC*ζ* is activated by PI3K in the setting of NMDA receptor activation.

PI3K is also involved in the pleiotropic Akt phosphorylation pathway.^[@bib43]^ Immunoblots confirmed that wortmannin suppressed Akt phosphorylation in the neuron cultures. By contrast, inhibition of Akt function with triciribine showed no effect on NMDA-induced superoxide formation ([Supplementary Figure 3](#sup1){ref-type="supplementary-material"}), thus excluding a role for Akt in this process.

PI3K inhibition prevents phosphorylation of PKC*ζ* and p47^phox^
----------------------------------------------------------------

Although phosphorylation of ser328 on p47^phox^ is required for its assembly with other NOX2 complex proteins,^[@bib20]^ it is possible that PKC*ζ* activation could lead to NOX2 activation by a route independent of p47^phox^. Immunostaining for phospho-ser328 p47^phox^ confirmed that phosphorylation at this site is induced by NMDA, and not ionomycin ([Figures 6a and b](#fig6){ref-type="fig"}). The phosphorylation was blocked by both wortmannin and a Tat-conjugated PKC*ζ* inhibitory peptide previously shown to prevent neuronal NOX2 activation,^[@bib5]^ thus placing this event downstream of PI3K and PKC*ζ*. Evaluation of PKC*ζ* phosphorylation showed a parallel result: NMDA (but not ionomycin)-induced phosphorylation of PKC*ζ* at the Thr(410/403) residue(s) required for its activation,^[@bib44]^ and this phosphorylation was also blocked by wortmannin ([Figures 6c and d](#fig6){ref-type="fig"}).

Discussion
==========

Superoxide production is a requisite event in the excitotoxic cell death process triggered by NMDA receptor activation,^[@bib6],\ [@bib7],\ [@bib12]^ and superoxide is a major source of oxidative stress in brain ischemia and other neurological disorders.^[@bib16],\ [@bib17],\ [@bib18]^ Results presented here show that NMDA induces superoxide production through a signaling pathway involving PI3K. Calcium influx through NR2B-containing NMDA receptors is coupled by PI3K to the activation of PKC*ζ*, with resultant phosphorylation of p47^phox^ ([Figure 7](#fig7){ref-type="fig"}). Phosphorylation of p47^phox^ leads to assembly of an activated NOX2 complex and extracellular release of superoxide. Perturbations in this pathway have the potential to either increase or decrease superoxide production in response to NMDA receptor activation, and may thus be relevant to the many neurological disorders, in which excitotoxic cell death occurs.

Calcium influx has long been established as a requisite event in excitotoxicity,^[@bib35]^ but it has been difficult to resolve whether the route of calcium influx is important in this process.^[@bib33],\ [@bib38],\ [@bib45]^ Tymianski and colleagues^[@bib8],\ [@bib46]^ showed that NMDA-induced nitric oxide production requires calcium influx specifically through NMDA receptors. Similarly, in the pathway described here, calcium influx gated by NR2B-containing NMDA receptors leads to NOX2 activation and cell death, whereas ionomycin-induced calcium elevations of comparable magnitude do not. These results demonstrate that calcium influx gated specifically by NMDA receptors can trigger excitotoxic death, and they are also consistent with recent studies implicating NR2B-containing receptors as selectively responsible for excitotoxic neuronal death.^[@bib33]^ On the other hand, our findings that high intracellular calcium elevations induced by ionomycin trigger superoxide production and cell death by a mechanism independent of NOX2 (presumably from mitochondria) illustrates that other routes of calcium-mediated neuronal death may also be contributory.

Ligand binding to NR2B-containing NMDA receptors activates PI3K by mechanisms involving binding between NR2B, the adapter protein APPL1, and the p85 regulatory subunit of PI3K.^[@bib39],\ [@bib47],\ [@bib48]^ Our findings show that NR2B-containing NMDA receptors elicit NOX2 activation by a mechanism that is blocked by the PI3K inhibitor, wortmannin. Wortmannin may have effects other than PI3K inhibition, but three lines of evidence argue that the effects of wortmannin on NMDA-induced NOX2 activation are due specifically to PI3K inhibition. First, events identified as downstream of PI3K were blocked by wortmannin (AKT phosphorylation, PKC*ζ* phosphorylation, p47^phox^ phosphorylation, superoxide production, and cell death), whereas those occurring upstream or independent of PI3K were not (calcium influx, mitochondrial depolarization, and cell swelling); second, the inhibitory effect of wortmannin on superoxide formation was reversed by exogenous delivery of the PI3K product, PI(3,4,5)P3; and third, the inhibitory effect of wortmannin on superoxide formation was similarly reversed in neurons transfected with PKM, a constitutively active form of PKC*ζ* that does not require PI3K activation.^[@bib41],\ [@bib42]^

The organizing p47^phox^ subunit of NOX2 can be phosphorylated (activated) by PKC*ζ*. The role of PKC*ζ* in this process was confirmed here using an inhibitory pseudosubtrate peptide.^[@bib49]^ This peptide inhibitor can have off-target effects,^[@bib50],\ [@bib51]^ but the role of PKC*ζ* in NMDA-induced p47^phox^ phosphorylation is also demonstrated by the observation that transfection with a constitutively active form of PKC*ζ* negates the effect of wortmannin. The mechanism by which PI3K activates PKC*ζ* has not been resolved, but may involve either direct interaction between PI(3,4,5)P3 with PKC*ζ*,^[@bib52]^ or an indirect effect mediated by PI(3,4,5)P3 stimulation of PDK1 phosphorylation of PKC*ζ*.^[@bib53]^ Of note, neither exogenous PI(3,4,5)P3 nor transfection with PKM induced superoxide formation in the absence of NMDA receptor stimulation ([Figure 5b](#fig5){ref-type="fig"}). This result is not unexpected, however, because activation of NOX2 requires not only the signaling pathway described here, but also p47^phox^ phosphorylation at additional sites and the concomitant activation of both rac1 and phospholipase A2.^[@bib54]^

The role of PI3K in excitotoxicity and oxidative stress identified here contrasts with the well-established prosurvival effects of PI3K mediated by the Akt pathway.^[@bib43]^ Previous work has demonstrated that prosurvival pathways required for neuroprotection in developing neurons is dependent on NMDA-induced activation of PI3K,^[@bib55],\ [@bib56]^ and selective disruption of NMDA-induced Akt signaling results in widespread apoptosis.^[@bib39]^ The contrasting toxic and trophic roles of NMDA-induced PI3K activity may be reconciled, however, given that both PI3K and superoxide have also been independently identified as mediators of intercellular signaling and synaptic plasticity in the nervous system.^[@bib21],\ [@bib25],\ [@bib57]^ The cytotoxic, PI3K-dependent superoxide production that occurs during sustained NMDA receptor activation may thus be an exaggerated, pathological manifestation of normal intercellular signaling.

Materials and Methods
=====================

Studies were performed in accordance with protocols approved by the San Francisco Veterans Affairs Medical Center animal studies subcommittee. Wild-type and p47^phox−/−^ mice on the C57/Bl6 background were obtained from the Jackson Laboratories (Bar Harbor, ME, USA). The p47^phox−/−^ mice were maintained as homozygotes with the use of fresh breeder stock, fully back-crossed to wt C57/Bl6 mice, after every eight generations. Cell culture reagents were obtained from Mediatech (Manassas, VA, USA), and all other reagents were obtained from Sigma-Aldrich (St Louis, MO, USA) except where noted. Data analyses for all studies were performed by observers blinded to the experimental conditions.

Neuron cultures
---------------

Cultures were prepared from the cortices of embryonic day 15 mice and plated in 24-well culture plates or poly-*D*-lysine coated glass coverslips.^[@bib58]^ After 1 day in culture, 10 *μ*M cytosine arabinoside was added for 24 h to prevent glial proliferation. The neurons were subsequently maintained with serum-free NeuroBasal medium (Gibco, Grand Island, NY, USA) containing 5 mM glucose, and used at day 10--12 *in vitro*. These cultures contain\>95% neurons and no detectable microglia.^[@bib58]^ Experiments were initiated by exchanging the culture medium with a low-magnesium balanced salt solution (BSS): 1.2 mM CaCl~2~, 0.4 mM MgSO~4~, 5.3 mM KCl, 0.4 mM KH~2~PO~4~, 137 mM NaCl~2~, 0.3 mM NaHPO~4~, 5 mM glucose, and 10 mM 1,4-piperazinediethanesulfonate buffer, pH 7.2. Drugs were added from concentrated stocks 10 min before the addition of NMDA.

Immunostaining
--------------

Formaldehyde-fixed cultures were immunostained as described previously,^[@bib5],\ [@bib58]^ using rabbit antibody to 4-hydroxynonenal (Alpha Diagnostics, San Antonio, TX, USA; 1 : 500), rabbit antibody to phospho-PKC*ζ*/*λ* (Thr410/403; Cell Signaling, Danvers, MA, USA; 1 : 100), and mouse antibody to microtubule-associated protein 2 (Chemicon, Temecula, CA, USA; 1 : 500). Antibody binding was visualized with Alexa Fluor 488-conjugated anti-mouse IgG or Texas Red 594-conjugated anti-rabbit IgG (Invitrogen, Grand Island, NY, USA). Antibodies to detect to phospho-p47^phox^ (Ser 328) were a generous gift from from J El Benna, Paris. For studies with this antibody, fixation was performed with 0.5% glutaraldehyde followed by borohydride reduction. Images were obtained using confocal fluorescence microscopy using step-wise 1 *μ*M z-stack sampling. In some cases cell nuclei were also identified for fluorescence imaging by incubation with 1 *μ*M 4′,6-diamidino-2-phenylindole after antibody removal. For quantification of neuronal 4HNE, phospho-PKC*ζ*/*λ*, and phospho-p47^phox^ immunostaining, the mean fluorescence intensity was obtained over the area defined by MAP-2 fluorescence. Neurons were analyzed in three randomly chosen optical fields from each of four coverslips per experiment, with\>100 neurons per coverslip, for a total of 400--500 neurons per '*n*\'.

Western blots
-------------

Cells were lysed in 50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1% SDS, and protease inhibitor (Roche, Pleasanton, CA, USA). Protein homogenates were sonicated, diluted in Laemmli buffer, and eletrophoretically separated on SDS-PAGE gels (Bio-Rad, Hercules, CA, USA). Proteins were transferred to PVDF membranes and incubated with antibodies diluted in Tris buffer saline containing 0.1% Tween-20 and 5% milk protein. Antibodies used were anti-phospho-Bad(Ser99) (Millipore, Billerica, MA, USA), anti-phospho-Akt(Ser473) (Cell Signaling), and anti-Akt (Cell Signaling). After rinsing, membranes were incubated with secondary antibodies coupled to horseradish peroxidase (Vector Laboratories, Burlingame, CA, USA), and antibody binding was detected using the ECL or ECL Plus substrate (GE Healthcare, Pittsburgh, PA, USA).

Peptide inhibitors
------------------

Tat-conjugated peptide inhibitors targeting PKC*ζ* and gp91 and scrambled sequence control peptide were commercially generated (CPC Scientific, Sunnyvale, CA, USA), using amino acid sequences described.^[@bib31],\ [@bib49]^

Eth imaging of superoxide production
------------------------------------

Five micromolars of dihydroethidium (Invitrogen) was added to cultures 10 min before the start of the experiment, and maintained throughout. The cultures were photographed at the specified time points with a fluorescence microscope (Axiovert 40 CFL, Zeiss, Thornwood, NY, USA) using 510--550 nm excitation and\>580 nm emission, and with transmitted light phase contrast. The fluorescence of oxidized Eth species was measured in three randomly chosen optical fields from each culture well and calculated as Eth fluorescence area × intensity, normalized to cell number. The cell number was counted in the corresponding phase contrast images of each optical field. In some cases, neurons were also identified under fluorescence imaging using Fura-2 in non-ratiometric mode. Measurements were made in four wells per experiment, with\>100 neurons per well for a total of 400--500 neurons per '*n*\'. For real-time imaging, images were acquired at 1 min intervals (40 ms exposure). The change in raw fluorescence for each neuron within the field of view was then normalized to baseline fluorescence, and these data were quantified by integrating the change from baseline over the 30-min observation intervals. Each '*n*\' value was the calculated mean response of 8--12 neurons per coverslip. Superoxide (or a superoxide metabolite) was confirmed as the reactive oxidant by negation of Eth formation in the studies where NOX2 activity was blocked.

Intracellular calcium and mitochondrial membrane potential imaging
------------------------------------------------------------------

Neurons were loaded for 30 min with either 4 *μ*M Fura-2 AM or Fura-FF AM (Molecular Probes, Grand Island, NY, USA) and washed once with BSS before imaging. When simultaneous detection of mitochondrial membrane potential was conducted, Fura was removed and exchanged for BSS containing 1 nM TMRM (Molecular Probes) for 20 min at 37 °C, and maintained in 1 nM TMRM throughout recordings. Images were acquired at 30 s intervals, using excitation that alternated between 340 and 380 nm (emission\>510 nm) for Fura-2 (or Fura-FF), and 510--550 nm excitation (\>580 nm emission) for TMRM. Calcium changes levels were expressed as change in the 340/380 nm signal ratio relative to baseline fluorescence (ΔF/F~0~), and quantified by integrating the change over baseline over 30-min observation intervals. Regions of interests for TMRM fluorescence were drawn around populations of mitochondria. In a subset of experiments, application of FCCP (3 *μ*M) caused an increase in cytosolic TMRM fluorescence immediately adjacent to depolarizing mitochondria, thus confirming that observed reductions in the TMRM fluorescence were due to TMRM efflux from the mitochondria.

Plasmids and neuronal transfections
-----------------------------------

Plasmid coding for p47^phox^-GFP was a generous gift from Dr. Lance Terada, University of Texas Southwestern, and the corresponding empty vector was eGFP-N1 (BD Bioscience, San Jose, CA, USA). PKM (Genebank accession NM_001039079) was amplified with primers 5′-tgcgaattcaatggattctgtcatgccttcc-3′ and 5′-attgtcgactcacacggactcctcagcag-3′ from adult mouse brain cDNA, digested with EcoR I and Sal I, and ligated into the pIRES-hr-GFP (Agilent, Santa Clara, CA, USA) vector. Sequencing confirmed that the coding frame of PKM was fused with a 3xFlag tag and followed by a stop codon and an IRES-hr-GFP codon. Expression of the expected PKM-IRES-hrGFP in transfected HEK293 cells was confirmed by western blots probed with anti-flag antibody. Neuronal transfections were performed on culture day 6 or 7 using Lipofectamine 2000 (Invitrogen).

Intracellular delivery of phospholipids
---------------------------------------

PI(3,4,5)P3, PI(4,5)P2, and the BODIPY-labeled cell-permeable carrier were commercially purchased (Echelon, Salt Lake City, UT, USA). The phospholipids and the carrier were reconstituted at 1 mM in BSS, combined at a 1 : 1 molar ratio for 10 min, and added to culture wells at a final concentration of 40 *μ*M.

Cell swelling
-------------

Cell morphology was evaluated in phase contrast images of unfixed cells. Neuronal soma were scored as swollen if they lost their normal angulated shape and assumed a rounded morphology. Neurons were evaluated in three randomly chosen fields in a minimum of four wells per plate for each independent experiment. Results from each experiment were expressed as the percent of neurons that had a swollen morphology.

Cell death
----------

Dead neurons were identified by staining with either trypan blue or, in studies using fluorescence markers, with propidium iodide, 24 h after NMDA exposures.^[@bib59]^ Live and dead neurons were counted in three randomly chosen fields in a minimum of four wells per plate, and results of each experiment were expressed as the percent of neurons that were dead.

Statistical analyses
--------------------

In all cases, the '*n*\' values denote the number of independent experiments, each using neurons prepared from different mice. Each independent experiment contained triplicate culture wells or coverslips of each study condition, with measurements obtained from at least 200 neurons in each well from a 24-well plate or an average of 10 neurons per each coverslip. Data are expressed as means±S.E.M. and assessed using one-way ANOVA followed by the Tukey--Kramer test where multiple groups are compared against one another, or Dunnett\'s test where multiple groups are compared against a common control group.
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![Excitotoxic neuronal superoxide production is mediated by NOX2 and triggered by NR2B-containing NMDA receptors. (**a**) NMDA-induced formation of oxidized dihydroethidium in cortical neurons is dose-dependent \**P*\<0.05 *versus* control, (*n*=3). All NMDA exposures are 30 min. (**b**) NMDA-induced neuronal death is also dose-dependent, and roughly parallel to superoxide production \**P*\<0.05 *versus* control, *n*=3). (**c**) Formation of 4HNE (red) in wild-type mouse cortical neurons after 30 min incubation with 100 *μ*M NMDA. Neuronal processes are identified by MAP-2 (green), and nuclei by 4′,6-diamidino-2-phenylindole, DAPI (blue). NMDA-induced 4HNE formation was blocked by the Tat-conjugated NOX2 peptide inhibitor, gp91ds-Tat (5 *μ*M), but not by the scrambled sequence peptide (Scr-Tat; 5 *μ*M). 4HNE formation was also blocked by the NR2B inhibitor, Ro 25-6981 (0.5 *μ*M), and not induced by ionomycin (3 *μ*M). Scale bar 20 *μ*m. (**d**) Similar results were obtained using oxidized Eth species ( red) as a marker of superoxide formation. Scale bar 10 *μ*m. \**P*\<0.01 *versus* NMDA, *n*=3. (**e**) Quantification of 4HNE staining shown in (**c**). \**P*\<0.05 *versus* NMDA, *n*=3. (**f**) Quantification of Eth fluorescence shown in (**d**). \**P*\<0.05 *versus* NMDA, *n*=3](cddis2013111f1){#fig1}

![NOX2-competent neurons produce oxidative stress and cell death in neighboring neurons after NMDA exposure. Neuronal cultures were prepared from p47^phox^-deficient (NOX2-incompetent) mice and transfected with p47^phox^-GFP (p47^phox^, green) to reconstitute NOX2 function in a subset of the neurons. Control cultures were transfected with the GFP tag alone (empty vector; green) (**a**). Oxidized Eth species (red) in neurons treated with or without 100 *μ*M NMDA. Neuronal processes are identified by Fura-2 (blue). Scale bar=10 *μ*m. (**b**) Quantification of Eth-positive neurons. EV, transfected with empty vector (GFP only), p47^phox^, transfected with GFP-tagged p47^phox^. \**P*\<0.01, *n*=3. (**c**) Dead neurons identified by propidium iodide staining (red) in neuronal cultures prepared from p47^phox^-deficient mice transfected with either GFP alone (empty vector; green) or p47^phox^-GFP (p47^phox^, green) and treated for 30 min with 100 *μ*M NMDA. Scale bar=10 *μ*m. (**d**) Quantification of neuronal death. Where indicated neurons were treated with 100 *μ*M NMDA together with 100 U superoxide dismutase-1, \**P*\<0.01 *versus* NMDA, *n*=3](cddis2013111f2){#fig2}

![Excitotoxic neuronal death is mediated by NOX2 and triggered by NR2B-containing NMDA receptors. (**a**) Trypan blue staining of dead neurons 24 h after 30-min exposure to 100 *μ*M NMDA, conditions as in [Figure 1C](#fig1){ref-type="fig"}. Scale bar 20 *μ*m. (**b**) Quantified cell death. \**P*\<0.05 *versus* NMDA, *n*=3. (**c**) Representative (of *n*=4) real-time calcium transients measured with Fura-2. Drugs were added after 5 min of baseline recording (arrow). (**d**) Representative trace of superoxide production as measured by Eth fluorescence in the same neurons as (**c**). Note Eth increase with NMDA but not ionomycin. (**e**) Quantified results; \**P*\<0.01 *versus* NMDA, *n*=3. (**f**) Representative traces of mitochondrial membrane potential, as evaluated using TMRM fluorescence in a separate set of experiments. Note mitochondrial depolarization with both NMDA and ionomycin. (**g**) Quantified results; \**P*\<0.01 *versus* NMDA, *n*=3](cddis2013111f3){#fig3}

![PI3K inhibition blocks NMDA-induced superoxide production and cell death. (**a**) Formation of 4HNE (red) in neurons after 30 min exposures to 100 *μ*M NMDA. Neuronal processes are identified by MAP-2 (green), and nuclei by DAPI (blue). 4HNE formation was blocked in cultures treated with 10 *μ*M wortmannin. Scale bar is 20 *μ*m. (**b**) Quantification of 4HNE formation. \**P*\<0.05 *versus* NMDA, *n*=3. (**c**) Phase contrast images of trypan blue staining shows that wortmannin prevents NMDA-induced neuronal death. (**d**) Quantification of neuronal death. \**P*\<0.05 *versus* NMDA, *n*=3. (**e**) Phase contrast images show cell swelling following NMDA application is not blocked by wortmannin. Scale bar is 20 *μ*m. (**f**) Quantification of neuronal swelling. \**P*\<0.01 *versus* control, *n*=3. (**g** and **h**) Wortmannin had no significant effect on NMDA-induced calcium elevations as measured by Fura-2, or on mitochondrial membrane potential as measured by TMRM. Representative of *n*=4](cddis2013111f4){#fig4}

![Lipid products of PI3K and transfection with constitutively active PKC*ζ* (PKM) reverse wortmannin inhibition of NMDA-induced superoxide formation. (**a**) Formation of oxidized dihydroethidium (red) in cortical neurons treated with NMDA is suppressed in cultures cotreated with wortmannin. Where indicated, neurons were also treated with the PI3K product, PI(3,4,5)P3 coupled to a cell permeable carrier tagged with BODIPY (green). The exogenously supplied PI(3,4,5)P3 restored NMDA-induced superoxide formation in the presence of wortmannin, but the PI3K substrate PI(4,5)P2 did not. Scale bar=20 *μ*m. (**b**) Quantification of Eth-positive neurons. \**P*\<0.01 *versus* control, *n*=3---6. (**c**) Formation of Eth (red) in neurons transfected with GFP-tagged PKM (green). Neurons were treated with NMDA (100 *μ*M) alone or with wortmannin (10 *μ*M). Scale bar 20 *μ*m. (**d**) Quantification of Eth-positive neurons.\**P*\<0.05 *versus* control; *n*=4](cddis2013111f5){#fig5}

![NMDA induces PI3K-dependent phosphorylation of PKC*ζ*, and PKC*ζ*-dependent phosphorylation of p47^phox^. (**a**) Immunostaining for phospho-PKC*ζ* (phosphorylated at Thr410/403; red). Neuronal processes are identified with antibody to MAP-2 (green). PKC*ζ* phosphorylation was induced by NMDA, but not by the calcium ionophore ionomycin. PKC*ζ* phosphorylation was blocked by both the NR2B inhibitor RO 25-6981 and the PI3K inhibitor wortmannin. Conditions as in [Figure 1a](#fig1){ref-type="fig"}. (**b**) Immunostaining for phospho-p47^phox^ (phosphorylated at Ser328; red). Phosphorylation was induced by NMDA, but not by ionomycin. p47^phox^ phosphorylation was blocked by both wortmannin and a Tat-conjugated peptide inhibitor of PKC*ζ*. Scale bars are 20 *μ*m. (**c** and **d**) Quantification of immunostaining. \**P*\<0.05 *versus* NMDA; *n*=4](cddis2013111f6){#fig6}

![Signaling pathway linking NMDA receptor activation to NOX2 superoxide production. Calcium influx via NR2B-containing NMDA receptors induces PI3K to form PI(3,4,5)P3. PI(3,4,5)P3 activates PKC*ζ*, which phosphorylates the p47^phox^ organizing subunit of NOX2. Phosphorylated p47^phox^ induces assembly of the active NOX2 complex at the cell surface and production of superoxide. Red lines indicate the targets of the probes used in these experiments](cddis2013111f7){#fig7}
